The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peripheral blood epigenetic immune-profiling and survival outcomes with anti-programmed death (PD)-1 based therapy in recurrent/metastatic (R/M) squamous cell carcinoma of head and neck (SCCHN).
 
Kartik Sehgal
Honoraria - Equinox Group; Exelixis; Medscape
Consulting or Advisory Role - Equinox Group; Exelixis; Medscape
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Ze Zhang
No Relationships to Disclose
 
Keisuke Shirai
Honoraria - Chugai Pharma; Eisai; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Rondi Butler
No Relationships to Disclose
 
Min Kyung Lee
No Relationships to Disclose
 
Annette Molinaro
No Relationships to Disclose
 
John Kirk Wiencke
No Relationships to Disclose
 
Devin Koestler
Patents, Royalties, Other Intellectual Property - U.S. Provisional Patent Application entitled: ENHANCED DNA METHYLATION LIBRARY FOR DECONVOLUTING PERIPHERAL BLOOD filed on February 12, 2021 by Dartmouth College for the IDOL deconvolution libraries invention
 
Lucas A Salas
Patents, Royalties, Other Intellectual Property - U.S. Provisional Patent Application entitled: ENHANCED DNA METHYLATION LIBRARY FOR DECONVOLUTING PERIPHERAL BLOOD filed on February 12, 2021 by Dartmouth College for the IDOL deconvolution libraries invention
 
Brock C Christensen
Patents, Royalties, Other Intellectual Property - U.S. Provisional Patent Application entitled: ENHANCED DNA METHYLATION LIBRARY FOR DECONVOLUTING PERIPHERAL BLOOD filed on February 12, 2021 by Dartmouth College for the IDOL deconvolution libraries invention
 
Karl Kelsey
Stock and Other Ownership Interests - Cellintec
Patents, Royalties, Other Intellectual Property - U.S. Provisional Patent Application entitled: ENHANCED DNA METHYLATION LIBRARY FOR DECONVOLUTING PERIPHERAL BLOOD filed on February 12, 2021 by Dartmouth College for the IDOL deconvolution libraries invention
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Consulting or Advisory Role - Achilles Therapeutics; AstraZeneca; Bayer; BioNTech; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Coherus Biosciences; Eisai; EMD Serono; Genentech; Genmab; Gilead Sciences; GlaxoSmithKline; Immunomic Therapeutics; Loxo; Merck; Mirati Therapeutics; Pfizer; Vaccinex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Boehringer Ingelheim; ISA Pharmaceuticals; Nanobiotix